- Filed
- Nov 7, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Nov 4, 2024 | 17.13M sh |
| Cash And Equivalents | Q2 2024 · Sep 30, 2024 | $138.35M |
| Cash And Equivalents | Q2 2024 · Mar 31, 2024 | $105.56M |
| Current Liabilities | Q2 2024 · Sep 30, 2024 | $212.86M |
| Current Liabilities | Q2 2024 · Mar 31, 2024 | $184.5M |
| Total Liabilities | Q2 2024 · Sep 30, 2024 | $235.78M |
| Total Liabilities | Q2 2024 · Mar 31, 2024 | $207.03M |
| Current Assets | Q2 2024 · Sep 30, 2024 | $363.33M |
| Current Assets | Q2 2024 · Mar 31, 2024 | $302.23M |
| Total Assets | Q2 2024 · Sep 30, 2024 | $518.55M |
| Total Assets | Q2 2024 · Mar 31, 2024 | $454.68M |
| Shares Diluted | Q2 2024 · Sep 30, 2023 | 17.35M sh |
| Shares Diluted | Q2 2024 · Sep 30, 2023 | 17.37M sh |
| Stock Repurchased | Q2 2024 · Sep 30, 2023 | $27.21M |
| Capex | Q2 2024 · Sep 30, 2023 | $12.28M |
| Operating Cash Flow | Q2 2024 · Sep 30, 2023 | $54.62M |
| Stockholders Equity | Q2 2024 · Sep 30, 2023 | $222.57M |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $206.98M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $202.18M |
| Eps Diluted | Q2 2024 · Sep 30, 2023 | $1.15 |
| Eps Diluted | Q2 2024 · Sep 30, 2023 | $2.29 |
| Eps Basic | Q2 2024 · Sep 30, 2023 | $1.16 |
| Eps Basic | Q2 2024 · Sep 30, 2023 | $2.32 |
| Sga Expense | Q2 2024 · Sep 30, 2023 | $19.54M |
| Sga Expense | Q2 2024 · Sep 30, 2023 | $35.99M |
| Net Income | Q2 2024 · Sep 30, 2023 | $19.9M |
| Net Income | Q2 2024 · Sep 30, 2023 | $39.7M |
| Gross Profit | Q2 2024 · Sep 30, 2023 | $44.25M |
| Gross Profit | Q2 2024 · Sep 30, 2023 | $86.13M |
| Cost Of Revenue | Q2 2024 · Sep 30, 2023 | $151.27M |
| Cost Of Revenue | Q2 2024 · Sep 30, 2023 | $299.64M |
| Revenue | Q2 2024 · Sep 30, 2023 | $195.52M |
| Revenue | Q2 2024 · Sep 30, 2023 | $385.78M |